Q9Z2X8 (KEAP1_MOUSE) Mus musculus (Mouse)
Kelch-like ECH-associated protein 1 UniProtKBInterProSTRINGInteractive Modelling
624 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
57 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of the Keap1 protein in complexed with the N-terminal region of the Nrf2 transcri… |
Heteromer Q60795; | 7×SO4; | ||||
| Assess | ||||||
| Structural basis for the defects of human lung cancer somatic mutations in the repression activity … |
Heteromer Q60795; | 9×SO4; | ||||
| Assess | ||||||
| Crystal structure of Keap1 complexed with Prothymosin alpha |
Heteromer P26350; | 5×SO4; | ||||
| Assess | ||||||
| Crystal structure of the Keap1 complex with a peptide base on ETGE motif. |
Heteromer Q60795; | 11×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Keap1 in Complex with Sequestosome-1/p62 |
Heteromer Q64337; | 9×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Keap1 in Complex with the N-terminal region of the Nrf2 transcription factor |
Heteromer Q60795; | 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of Keap1 in Complex with phosphorylated p62 |
Heteromer Q64337; | |||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 2×SO4; 7×DMS; 1×VBQ; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 2×SO4; 11×DMS; 1×VBW; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 2×SO4; 9×DMS; 1×VCB; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 5×SO4; 13×DMS; 1×QH2; | ||||
| Assess | ||||||
| Structural basis for the defects of human lung cancer somatic mutations in the repression activity … | monomer | 8×SO4; | ||||
| Assess | ||||||
| Small molecule inhibitor of the KEAP1-NRF2 protein-protein interaction | monomer | 1×CL; 1×J8H; | ||||
| Assess | ||||||
| Crystal structure of Keap1 in complex with fumarate (FUM) | monomer | 3×FUM; 2×ACT; 1×PGE; 2×SO4; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 2×SO4; 14×DMS; 1×QHZ; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with PGAM5-derived peptide | monomer | 4×SO4; | ||||
| Assess | ||||||
| Small molecule inhibitor of the KEAP1-NRF2 protein-protein interaction | monomer | 1×SO4; 1×J6Q; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×S0W; | ||||
| Assess | ||||||
| Crystal structure of Keap1 in complex with monoethyl fumarate (MEF) | monomer | 2×NF3; 1×ACT; 2×SO4; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×SO4; 1×FB2; | ||||
| Assess | ||||||
| Crystal structure of the Keap1 Kelch domain in complex with Caffeic acid | monomer | 1×CA; 1×TRS; 8×SO4; 1×DHC; | ||||
| Assess | ||||||
| Crystal structure of murine Keap1 in complex with RA839, a non-covalent small-molecule binder to Ke… | monomer | 4×SO4; 1×51M; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 3×SO4; 15×DMS; 1×QHW; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 1×QH5; 3×SO4; 12×DMS; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 2×SO4; 15×DMS; 1×QH8; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 3×SO4; 14×DMS; 1×QHQ; | ||||
| Assess | ||||||
| Small molecule inhibitor of the KEAP1-NRF2 protein-protein interaction | monomer | 1×J6H; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×CL; 1×0PL; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×CL; 1×5UZ; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×XYY; 1×CL; | ||||
| Assess | ||||||
| Small molecule inhibitor of the KEAP1-NRF2 protein-protein interaction | monomer | 1×SO4; 1×CL; 1×J6K; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×CL; 1×SO4; 1×5X9; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×DMS; 1×CL; 1×5VX; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×DMS; 1×CL; 1×5UI; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×XMS; | ||||
| Assess | ||||||
| Small molecule inhibitor of the KEAP1-NRF2 protein-protein interaction | monomer | 1×DMS; 2×J6N; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 4×DMS; 1×VCT; 1×SO4; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 6×DMS; 1×QHN; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×75K; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 1×VBT; 1×DMS; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 1×SO4; 6×DMS; 1×VCN; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 1×QHH; | ||||
| Assess | ||||||
| Crystal structure of the human Kelch domain of Keap1 in complex with compound S217879 | monomer | 1×L5F; | ||||
| Assess | ||||||
| mouse Keap1 in complex with stapled peptide | monomer | 1×SO4; 1×NA; 1×IZS; | ||||
| Assess | ||||||
| mouse Keap1 in complex with stapled peptide | monomer | 1×SO4; 1×IZS; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 8×DMS; 1×SO4; 1×QHB; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 1×SO4; 10×DMS; 1×QHT; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 1×SO4; 9×DMS; 1×QHK; | ||||
| Assess | ||||||
| Structure of the Keap1 Kelch domain in complex with a small molecule inhibitor. | monomer | 1×L6I; 1×CL; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 1×VCQ; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule fragment | monomer | 1×VBK; 1×DMS; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 5×DMS; 1×QGZ; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×CL; 1×SO4; 1×5RB; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×CL; 1×5QZ; | ||||
| Assess | ||||||
| Pyrazole Carboxylic Acid Inhibitors of KEAP1:NRF2 interaction | monomer | 1×CL; 1×5RQ; | ||||
| Assess | ||||||
| Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction | monomer | 4×DMS; 1×SO4; 1×QJ5; | ||||
| Assess | ||||||
| Crystal Structure of Keap1 in Complex with a small chemical compound, K67 | monomer | 1×FMT; 1×K67; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2dyh.1.A | monomer | 0.91 | 99.68 | |||
| Assess | ||||||
| 6wcq.1.C | monomer | 0.76 | 93.91 | |||
| Assess | ||||||